|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
4450184 |
003 |
ICU |
005 |
20031020180400.0 |
008 |
980924s1999 sz a b 001 0 eng c |
010 |
|
|
|a 98046288
|
020 |
|
|
|a 380556757X (acid-free paper)
|
035 |
|
|
|a 98046288
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OCoLC
|d OrLoB-B
|
050 |
0 |
0 |
|a RM291.2.S6
|b C87 1999
|
060 |
1 |
0 |
|a WK 550
|b C976 1999
|
082 |
0 |
0 |
|a 615/.363
|2 21
|
245 |
0 |
0 |
|a Current indications for growth hormone therapy /
|c volume editor, P.C. Hindmarsh.
|
260 |
|
|
|a Basel ;
|a New York :
|b Karger,
|c c1999.
|
300 |
|
|
|a viii, 161 p. :
|b ill. ;
|c 25 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Endocrine development ;
|v vol. 1
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|t Foreword /
|r M. O. Savage --
|t Preface /
|r P. C. Hindmarsh --
|g 1.
|t Evidence-Based Decisions in Growth Hormone Therapy /
|r P. C. Hindmarsh --
|g 2.
|t Methodological Issues for Clinical Trials in Growth Hormone Therapy /
|r V. T. Farewell and R. J. Cook --
|g 3.
|t Health Economic and Health Benefit Issues in Endocrine Trials /
|r S. Thompson and M. Drummond --
|g 4.
|t Growth Hormone Deficiency /
|r G. Saggese, G. Federico and S. Barsanti --
|g 5.
|t Use of Growth Hormone in Idiopathic Short Stature /
|r C. T. Cowell, M. E. Craig and G. R. Ambler --
|g 6.
|t Growth Hormone Treatment of Short Children Born Small for Gestational Age /
|r P. Czernichow --
|g 7.
|t Current Indications for Growth Hormone Therapy: Skeletal Dysplasia /
|r N. Bridges --
|g 8.
|t Managing the Short Stature of Turner Syndrome: An Evidence-Based Approach to the Suggestion of Growth Hormone Supplementation /
|r S. P. Taback and G. Van Vliet --
|g 9.
|t Effectiveness of Growth Hormone Therapy in Noonan Syndrome /
|r A. M. Cotterill --
|g 10.
|t Growth Retardation in Children with Chronic Renal Disease - Pathophysiology and Treatment /
|r B. Tonshoff and O. Mehls.
|
583 |
1 |
|
|a committed to retain
|c 20170930
|d 20421213
|f HathiTrust
|5 ICU
|
650 |
|
0 |
|a Somatotropin
|x Therapeutic use.
|
650 |
1 |
2 |
|a Growth Disorders
|x drug therapy.
|
650 |
2 |
2 |
|a Human Growth Hormone
|x therapeutic use.
|
650 |
2 |
2 |
|a Bone Diseases, Developmental
|x drug therapy.
|
650 |
2 |
2 |
|a Noonan Syndrome
|x drug therapy.
|
650 |
|
7 |
|a Somatotropin
|x Therapeutic use.
|2 fast
|0 http://id.worldcat.org/fast/fst01125757
|
700 |
1 |
|
|a Hindmarsh, P. C.
|q (Peter C.)
|0 http://id.loc.gov/authorities/names/n98802855
|1 http://viaf.org/viaf/17380416
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
903 |
|
|
|a Hathi
|
035 |
|
|
|a (OCoLC)39982636
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 478df451-72f7-5320-a08b-88ce3b2d6d90
|s cb1243a9-b9c2-5fad-9c0a-2ae91d875153
|
928 |
|
|
|t Library of Congress classification
|a RM291.2.S6 C87 1999
|l JCL
|c JCL-Sci
|i 4385819
|
927 |
|
|
|t Library of Congress classification
|a RM291.2.S6 C87 1999
|l JCL
|c JCL-Sci
|e CRERAR
|b 60081476
|i 7045347
|